UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 458

Sortiert nach

Diagnostic criteria for primary osteoporosis: year 2012 revision

Journal of bone and mineral metabolism, 2013-05, Vol.31 (3), p.247-257

2013

Volltextzugriff (PDF)

Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)

Journal of bone and mineral metabolism, 2013-01, Vol.31 (1), p.1-15

2013

Volltextzugriff (PDF)

Long-term use of dienogest for the treatment of endometriosis

The journal of obstetrics and gynaecology research, 2009-12, Vol.35 (6), p.1069-1076

2009

Volltextzugriff (PDF)

Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)

Clinica chimica acta, 2019-11, Vol.498, p.101-107

2019

Volltextzugriff (PDF)

Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

The journal of clinical endocrinology and metabolism, 2014-07, Vol.99 (7), p.2599-2607

2014

Volltextzugriff (PDF)

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind study

Bone (New York, N.Y.), 2011-10, Vol.49 (4), p.605-612

2011

Volltextzugriff (PDF)

A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo‐controlled trial

Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2735-2743

2010

Volltextzugriff (PDF)

Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial

Fertility and sterility, 2009-03, Vol.91 (3), p.675-681

2009

Volltextzugriff (PDF)

Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

Archives of osteoporosis, 2012-12, Vol.7 (1-2), p.3-20

2012

Volltextzugriff (PDF)

Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2021-11, Vol.26 (6), p.1085-1093

2021

Volltextzugriff (PDF)

Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol

Journal of bone and mineral metabolism, 2013-07, Vol.31 (4), p.417-422

2013

Volltextzugriff (PDF)

Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis

Radiology, 2008-08, Vol.248 (2), p.531

2008

Volltextzugriff (PDF)

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

Journal of bone and mineral metabolism, 2008-01, Vol.26 (1), p.93-100

2008

Volltextzugriff (PDF)

Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04

Current medical research and opinion, 2020-11, Vol.36 (11), p.1847-1859

2020

Volltextzugriff (PDF)

Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT

Bone (New York, N.Y.), 2011-09, Vol.49 (3), p.328-334

2011

Volltextzugriff (PDF)

Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04

Journal of bone and mineral metabolism, 2019-05, Vol.37 (3), p.491-495

2019

Volltextzugriff (PDF)

Fracture Prediction From Bone Mineral Density in Japanese Men and Women

Journal of bone and mineral research, 2003-08, Vol.18 (8), p.1547-1553

2003

Volltextzugriff (PDF)

Effects of different types of jump impact on trabecular bone mass and microarchitecture in growing rats

PloS one, 2014-09, Vol.9 (9), p.e107953-e107953

2014

Volltextzugriff (PDF)

Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis

Journal of bone and mineral metabolism, 2013-03, Vol.31 (2), p.183-189

2013

Volltextzugriff (PDF)

Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03

Journal of bone and mineral metabolism, 2017-07, Vol.35 (4), p.385-395

2017

Volltextzugriff (PDF)

Differential effects of jump versus running exercise on trabecular architecture during remobilization after suspension-induced osteopenia in growing rats

Journal of applied physiology (1985), 2012-03, Vol.112 (5), p.766-772

2012

Volltextzugriff (PDF)

Three years of treatment with minodronate in patients with postmenopausal osteoporosis

Journal of bone and mineral metabolism, 2012-07, Vol.30 (4), p.439-446

2012

Volltextzugriff (PDF)

A New Active Vitamin D, ED-71, Increases Bone Mass in Osteoporotic Patients under Vitamin D Supplementation: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

The journal of clinical endocrinology and metabolism, 2005-09, Vol.90 (9), p.5031-5036

2005

Volltextzugriff (PDF)

Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial

Journal of bone and mineral metabolism, 2014-07, Vol.32 (4), p.441-446

2014

Volltextzugriff (PDF)

Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90‐Day Bed Rest

Journal of bone and mineral research, 2004-11, Vol.19 (11), p.1771-1778

2004

Volltextzugriff (PDF)

1 – 25 von 458

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(400)

Publikationsform

Sprache

Englisch
(345)
Japanisch
(233)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Humans
(170)
Life Sciences & Biomedicine
(144)
Female
(111)
Male
(99)
Middle Aged
(90)
Aged
(76)
Biological And Medical Sciences
(73)
Endocrinology & Metabolism
(62)
Adult
(61)
Medical Sciences
(59)
Osteoporosis
(53)
Bone Density
(44)
Medicine, Research & Experimental
(40)
Research & Experimental Medicine
(40)
Aged, 80 And Over
(37)
Bone Mineral Density
(36)
Diseases Of The Osteoarticular System
(29)
Medicine
(29)
Orthopedics
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnostic criteria for primary osteoporosis: year 2012 revision

Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)

Long-term use of dienogest for the treatment of endometriosis

Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)

Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind study

A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo‐controlled trial

Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial

Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy

Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol

Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04

Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT

Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04

Fracture Prediction From Bone Mineral Density in Japanese Men and Women

Effects of different types of jump impact on trabecular bone mass and microarchitecture in growing rats

Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis

Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03

Differential effects of jump versus running exercise on trabecular architecture during remobilization after suspension-induced osteopenia in growing rats

Three years of treatment with minodronate in patients with postmenopausal osteoporosis

A New Active Vitamin D, ED-71, Increases Bone Mass in Osteoporotic Patients under Vitamin D Supplementation: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial

Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90‐Day Bed Rest

Suchergebnisse filtern